🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
The study evaluates the long-term safety and efficacy of elexacaftor (ELX)/...
Status
Completed
Location
Telethon Kids Institute
Start Date
2021-01-11
Trial ID
NCT04545515
Treatments Being Tested
To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02508207
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
This is a prospective, single-center, fixed-sequence, nonrandomized, open-l...
Status
Completed
Location
University of Southern California
Start Date
2022-05-09
Trial ID
NCT04840862
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics, safety, tole...
Status
Active Not Recruiting
Location
Children's Hospital of Orange County
Start Date
2022-06-21
Trial ID
NCT05422222
Treatments Being Tested
This study was evaluate the effect of elexacaftor (ELX)/tezacaftor (TEZ)/iv...
Status
Completed
Location
Royal Adelaide Hospital
Start Date
2021-01-15
Trial ID
NCT04599465
Treatments Being Tested
The purpose of this study is to evaluate the effect of multiple doses of va...
Status
Completed
Location
Altasciences - Kansas City
Start Date
2026-01-12
Trial ID
NCT07349394
Treatments Being Tested
The purpose of the study is to evaluate the long-term safety, tolerability,...
Status
Active Not Recruiting
Location
The Kids Research Institute Australia
Start Date
2024-11-21
Trial ID
NCT06460506
Treatments Being Tested
This is a Phase 2, randomized, double blind, placebo and active-controlled,...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT02951195